Diabetes Kongress 2019
Kalender
Liste
Personen
Favoriten
zur Liste
Dr. William Abraham
The Ohio State University
United States
Vortrag
Design of the Effect of EMPaglifozin on ExeRcise ability and HF-symptoms, In patients with chronic heArt faiLure (EMPERIAL) trials of empagliflozin in patients with chronic heart failure with reduced or preserved ejection fraction
Speaker
Datum: 31.05.2019 , Zeit: 11:40
|
Thema: 03. Grundlagenforschung Typ-1-Diabetes/ Betazelle/ Typ-1-Diabetes/ Adipositas/ Fettgewebe
Details